CoviVac vaccine shows promise for seniors in new trial

NCT ID NCT05765773

Completed ⭐️ VACCINE ⭐️ Sponsor: Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the CoviVac COVID-19 vaccine in 200 healthy adults aged 60 and older. Researchers checked how safe the vaccine was and how well it boosted the immune system. The goal was to see if the vaccine could help prevent COVID-19 in this age group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONA VIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Coronavinae infectious disease Orthocoronavirinae infectious disease COVID-19 prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONA VIRUS INFECTION COVID-19 VACCINE

Contacts and locations

Locations

FSBSI Chumakov FSC R&D IBP RAS

Moscow, Moscow, 108819, Russia
Federal State Budgetary Educational Institution of Higher Education "Perm State Medical University named after Academician E.A. Wagner" of the Ministry of Health of the Russian Federation

Perm, Perm Krai, 614990, Russia
Federal State Budgetary Healthcare Institution "Medical and Sanitary Unit No. 163 of the Federal Medical and Biological Agency"

Novosibirsk, Novosibirsk Oblast, 630559, Russia
Federal State Budgetary Scientific Institution "I.I. Mechnikov Scientific Research Institute of Vaccines and Serums"

Moscow, Moscow, 105064, Russia
Limited Liability Company "Scientific Research Center Ecosecurity"

Moscow, Moscow, 196143, Russia
Private healthcare institution "Clinical Hospital "Russian Railways-Medicine" named after N.A. Semashko"

Moscow, Moscow, 109386, Russia
State Budgetary Healthcare Institution of the Moscow region "Elektrostal Central City Hospital"

Elektrostal, Moscow Oblast, 144000, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.